EU-funded Czech cancer prevention centre in Brno leverages AI and early detection to tackle Europe's growing oncology burden
By
Euractiv
Warm and crisp on the edges. A bagel with a bit of bite.
Summary
Czechia has opened a major new cancer prevention centre in Brno, the Centre for Oncological Prevention at the Masaryk Memorial Cancer Institute (MOÚ), as part of a €46.1 million modernisation project largely funded by the EU's NextGenerationEU. The centre focuses on earlier detection, artificial intelligence, and personalised prevention to address Europe's growing cancer burden. Czech Health Minister Adam Vojtěch called it an exceptionally important step, and EU Health Commissioner Várhelyi described it as a potential model for Europe.
Key quotes
· 2 pulledCzech Health Minister Adam Vojtěch described the opening as 'an exceptionally important step' for
EU Health Commissioner Várhelyi described the state-of-the-art cancer centre as a potential model for Europe
You might also wanna read
HistoSonics develops ultrasound-based histotripsy to destroy cancer tumors without surgery
HistoSonics, founded by biomedical engineer Zhen Xu, is developing histotripsy — a non-invasive technique that uses ultrasound to target and
flip.it·4d ago
Molecular glue approach doubles survival time for pancreatic cancer patients in breakthrough trial
Chemical biologist Gregory Verdine developed a novel approach to fighting cancer by using "molecular glues" to bind disease-causing proteins
pasadenastarnews.com·1h ago
Healthcare IT Weekly Roundup: AI Receptionists in 1 in 8 Practices, Teladoc-Walmart Partnership, and Industry Updates
This is a weekly roundup article from Healthcare IT Today titled "Bonus Features" covering 24 stories in the healthcare IT space. Key highli
Woman Alarmed After Therapist Uses AI to Record Private Therapy Sessions Without Consent
A 31-year-old woman, Molly Quinn, was alarmed when her trusted therapist began using an AI tool to record their private therapy sessions wit
trib.al·3h ago
Experimental pill daraxonrasib extends survival in advanced pancreatic cancer patients, study finds
Researchers reported that daraxonrasib, a novel experimental pill, helped patients with advanced pancreatic cancer live longer by blocking a
npr.org·3h ago
Experimental daraxonrasib pill nearly doubles survival time in advanced pancreatic cancer trial
A new experimental pill called daraxonrasib has shown promising results in extending survival for patients with advanced pancreatic cancer.
cnbc.com·4h ago